Journal of Medicinal Chemistry · 1991 · 57 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyMolecular VirologySynthetic Medicinal ChemistryVirologyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyViral InfectionsAcyclovir TherapyAntiviral Drug MechanismsAntiviral Mechanisms Of ActionAntiviral Structure-activity RelationshipsAntiviral TherapeuticsDirect-acting Antiviral AgentsNucleoside AnalogsNucleoside Analogue Antivirals
9-[(2-Hydroxyethoxy)methyl]guanine (acyclovir, 1a) and 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine (DHPG, ganciclovir, 1b) were transformed to their respective tricyclic derivatives, 3-substituted 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines 2b, 3a, and 3b. The 6-methyl-substituted compound 2b was obtained following reaction of 1b with bromoacetone. A two-step approach via 1-(2,2-diethoxyethyl) intermediates 4a,b was the most effective for the preparation of the derivatives unsubstituted in the appended ring (3a,b). The novel acyclonucleosides, in particular ganciclovir derivative 2b, proved markedly active against herpes simplex virus type 1 and 2, varicella-zoster virus, and cytomegalovirus.